Security record · archived quarter
TYRA
Tyra Biosciences, Inc. · Healthcare · Biotechnology
3Tracked holders
—Δ holders
674.98KShares held
$10.79MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | +2 | 26.25M | $838.89M | +9 | −7 |
| Q1 2026 | 71 | +10 | 23.52M | $900.04M | +12 | −2 |
| Q4 2025 | 61 | -1 | 13.06M | $343.28M | +1 | −2 |
| Q3 2025 | 17 | 0 | 6.63M | $92.78M | — | — |
| Q2 2025 | 14 | +2 | 5.95M | $56.99M | +2 | — |
| Q1 2025 | 9 | -1 | 2.08M | $19.36M | — | −1 |
| Q4 2024 | 10 | +1 | 1.73M | $24.09M | +2 | −1 |
| Q3 2024 | 8 | +5 | 939.26K | $22.08M | +5 | — |
| Q2 2024 | 3 | — | 674.98K | $10.79M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 522.67K | — | $8.36M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 522.67K | — | $8.36M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 117.03K | — | $1.87M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 117.03K | — | $1.87M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 117.03K | — | $1.87M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 117.03K | — | $1.87M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 35.27K | — | $563,999 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 163 holders, 65.87M shares, $2.48B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API